BRAFm+ Metastatic melanoma
What makes it different, makes it vulnerable

BRAF in melanoma

Identifying BRAF mutations

For patients with advanced melanoma, accurate, timely, and reliable identification of BRAF mutations is essential to ensure appropriate disease management.1

Here you’ll find information on the role of BRAF and the MAP kinase (MAPK) pathway, types of BRAF mutations and their role in the development and progression of melanoma, and an overview of BRAF inhibitor treatment.

  1. Dummer R, et al. ESMO Guidelines Committee. Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26(suppl 5):v126–32.